Bioethics Lunch - The Ethics of Business in Biology
The Biointerfaces Interlaboratory Committees and Dr. Barry Belmont invite you to join us for our July Bioethics lunch! This bioethics lunch will focus on the ethics of business in biology. With the recent rise of companies like 23andMe, which can provide personalized information about one's genetic makeup, it is becoming easier and easier to obtain information that could impact how and when we seek medical treatment and guidance. To what extent should these companies be regulated? Is it ethical to patent a gene? Should private companies be allowed to fund academic research? Should individuals be allowed to hold intellectual property rights over life-saving medical technology, or do we have a moral obligation to make these treatments freely available to anyone who needs them? Please join us for free lunch and insightful discussion!

For this discussion, we are very excited to be joined by Dr. David Canter - Executive Director of the North Campus Research Complex, former Senior VP of of Pfizer Global Research and Development, Fellow of the Royal College of Surgeons, and Instructor for the Business of Biology course at the Ross School of Business. Dr. Canter's diverse experience in healthcare, industry, and academia will be a great source of insight for our discussion!

When: Thursday, July 18th | 12:00 - 1:00 pm
Where: NCRC Building 10, G065


Please RSVP by Tuesday, July 16th!

Email address *
First Name *
Your answer
Last Name *
Your answer
PI *
Your answer
Will you attend the Bioethics Lunch? *
Food restrictions? (select all that apply)
Never submit passwords through Google Forms.
This form was created inside of University of Michigan. Report Abuse - Terms of Service